Clinical Trials Browser

Phase 4 × Leiomyoma × elagolix × Clear all

NCT03886220 2022-03-31

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Phase 4 Completed

82 enrolled 10 charts

Leiomyoma, Menorrhagia